Mirum Pharma Enters Catalyst Stretch
Mirum Pharmaceuticals approaches key milestones with LIVMARLI sales and pipeline progress, potentially impacting stock performance. This may lead to increased investor attention.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.